Europe blood and blood components market is projected to depict a rapid growth on account of increasing number of trauma cases, surgical procedures and road accidents. Rise in the number of surgical procedures in ambulatory surgical centers owing to shorter procedural time and focused care will offer significant potential for growth in the segment. Ambulatory surgical centers accounted for over $1.5 billion of the total Europe blood and blood components industry size in the year 2017.

The cancer treatment application segment is estimated to grow at a considerably faster rate due to the growing prevalence of several cancer forms. Blood components help compensate for lower blood cell count, bolstering the demand for blood components. Steady inclination towards unhealthy eating lifestyle in the European region will escalate cancer risks and further stimulate the regional growth.

Request for a sample copy of this report @ https://www.decresearch.com/request-sample/detail/3398

The trauma and surgery application segment had held more than 40% of Europe blood and blood components market share in 2017. Surge in the number of injuries that lead to a surgery will boost the demand for blood and blood components in the forthcoming years. Most trauma cases need massive amounts of blood transfusion.

There have been numerous awareness campaigns undertaken by prominent institutions in the region for promoting the donation of blood and blood components essential for cancer treatment. For instance, according to a report by Anthony Nolan and NHS Stem Cell Registry, over 1.4 million registrations were recorded for stem cell donations at the end of 2017. In many cases, stem cells and bone marrow can help with the cancer treatment and increases the chance of survival.

Prominent associations operational in Europe blood and blood components market are focused on implementing initiatives such as awareness campaigns, collaborations and expansion for gaining a strong presence in the market. Some of the renowned associations are NHS Blood and Transplant (NHSBT), Northern Ireland Blood Transfusion Service, international Federation of Red Cross and Red Crescent Societies and Welsh Blood Services.

Request for customization @ https://www.decresearch.com/roc/3398

Partial Chapter of the Table of Content

Chapter 4. Europe Blood and Blood Components Market, By Product

4.1. Key segment trends

4.2. Whole blood

4.2.1.1.Market size, by country, 2013 – 2024 (USD Million)

4.3. Blood components

4.3.1.1.Market size, by country, 2013 – 2024 (USD Million)

4.3.1.2.Market size, by country, 2013 – 2024 (Units)

4.3.2. Red blood cells

4.3.2.1. Market size, by country, 2013 – 2024 (USD Million)

4.3.2.2.Market size, by country, 2013 – 2024 (Units)

4.3.3. Platelets

4.3.3.1. Market size, by country, 2013 – 2024 (USD Million)

4.3.3.2.Market size, by country, 2013 – 2024 (Units)

4.3.4. Plasma

4.3.4.1. Europe blood and blood components market size, by country, 2013 – 2024 (USD Million)

4.3.4.2.Market size, by country, 2013 – 2024 (Units)

4.3.5. White blood cells

4.3.5.1. Market size, by country, 2013 – 2024 (USD Million)

4.3.5.2.Market size, by country, 2013 – 2024 (Units)

Chapter 5. Europe Blood and Blood Components Market, By Application

5.1. Key segment trends

5.2. Anemia

5.2.1.Market size, by country, 2013 – 2024 (USD Million)

5.3. Trauma & surgery

5.3.1.Market size, by country, 2013 – 2024 (USD Million)

5.4. Cancer treatment

5.4.1.Market size, by country, 2013 – 2024 (USD Million)

5.5. Bleeding disorders

Browse full table of contents (TOC) of this report @ https://www.decresearch.com/toc/detail/europe-blood-and-blood-components-market